Similar to the results of our study, a case-control study conducted by Xing et al. found that the PIK3CA polymorphism is a defense factor against follicular thyroid cancer (Xing et al., 2012). The gene discussed is PIK3CA; the disease is thyroid gland follicular carcinoma.